NASDAQ:TTOO

T2 Biosystems Stock News

Healthcare > Medical - Diagnostics & Research

Buy TTOO

*Your capital is at risk

$0.0020

+0 (+0%)

At Close: Jun 03, 2026

T2 Biosystems Showcases Research from Recent Industry Conferences

08:55am, Thursday, 14'th Oct 2021

Leading rapid diagnostics company shares highlights of comprehensive data presented at AACC, CAP21 and IDWeek Leading rapid diagnostics company shares highlights of comprehensive data presented at A

T2 Biosystems Announces BARDA Exercise of Contract Option 2A Valued at $6.4 Million

04:05pm, Monday, 04'th Oct 2021

Advances Development of Diagnostics for Sepsis-Causing Pathogens, Antibiotic Resistance, and Biothreat Pathogens Advances Development of Diagnostics for Sepsis-Causing Pathogens, Antibiotic Resistance

T2 Biosystems to Unveil New Data at September Conferences

10:05am, Tuesday, 14'th Sep 2021

Leading rapid diagnostics company to share new research at industry conferences throughout Sepsis Awareness Month Leading rapid diagnostics company to share new research at industry conferences throu

Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?

11:11am, Monday, 13'th Sep 2021

Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.

TTOO Stock: The Huge Covid-19 News Lifting T2 Biosystems Today

01:42pm, Friday, 10'th Sep 2021

T2 Biosystems has announced a breakthrough in Covid-19 variant testing. As a result, shares have rapidly shot up.

TTOO Stock: Why It Significantly Increased Today

07:46am, Friday, 10'th Sep 2021

The stock price of T2 Biosystems, Inc. (NASDAQ: TTOO) has significantly increased pre-market today. This is why it happened.

T2 Biosystems' Stock Jumps As Its COVID-19 Molecular Test Can Detect Mu, Iota Variants

06:47am, Friday, 10'th Sep 2021

T2 Biosystems Inc (NASDAQ:TTOO) announced that its T2SARS-CoV-2 Panel is capable of detecting the Mu (B.1.621) and Iota (B.1.526) variants, which were recently confirmed to be present in the U.S. A

T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Mu B.1.621 and Iota B.1.526 Variants of the SARS-CoV-2 Virus

04:52pm, Thursday, 09'th Sep 2021

LEXINGTON, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel—

T2 Biosystems Announces Plans to Consolidate and Expand Facilities in Massachusetts

05:20pm, Wednesday, 08'th Sep 2021

LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today plans to consolidate its existing

T2 Biosystems Recognizes Sepsis Awareness Month with Thought Leadership Campaign and Participation in Sepsis Alliance Health Equity Pledge

06:00pm, Wednesday, 01'st Sep 2021

Leading rapid diagnostics company aims to increase awareness of sepsis diagnosis, management and treatment Leading rapid diagnostics company aims to increase awareness of sepsis diagnosis, managemen

T2 Biosystems Q2 Earnings Edges Wall Street Estimates On Higher Test Panels Volumes, Expects Lower COVID-19 Test Sales In FY21

09:39am, Friday, 06'th Aug 2021

T2 Biosystems Inc's (NASDAQ: TTOO) second-quarter revenues rose 162% Y/Y to $6.7 million, slightly ahead of the consensus of $6.12 million, primarily due to increased test panel sales. The firm repo

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by